Publication Topic

Unice KM, Kreider ML, Panko JM. 2012. Use of a deuterated internal standard with pyrolysis-GC/MS dimeric marker analysis to quantify tire tread particles in the environment. Int J Environ Res Pub Health 9:4033–4055.

Knutsen JS, Kerger BD, Finley BL, Paustenbach DJ. 2012. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments. Risk Anal 33 (7):1237–1251; doi: 10.1111/j.1539-6924.2012.01927.x. PMID: 23278103.

Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. 2012. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol 42(2):119–146. doi: 10.3109/10408444.2011.636028. PMID: 22141364.

Finley BL, Monnot AD, Paustenbach DJ, Gaffney SH. 2012. Derivation of a chronic reference dose for cobalt. Regul Toxicol Pharmacol 64:491–503; doi: 10.1016/j.yrtph.2012.08.022. PMID: 22982439.

Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lilycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. 2012. Predicting later-life outcomes of early-life exposures. Environ Health Perspect 120:1353–1361; doi: 10.1289/ehp.1204934.

Schugg TT, Erlebacher A, Leibowitz S, Ma L, Muglio LJ, Rando OJ, Rogers JM, Romero R, von Saal FS, Wise LD. 2012. Fetal programming and environmental exposures: Implications for prenatal care and preterm birth. Ann NY Acad Sci 1276:37–46.

Racz L, Muller JG, Goel RK. 2012. Fate of selected estrogens in two laboratory scale sequencing batch reactors fed with different organic carbon sources. Bioresource Technol 110:35–41.

Mwanza JC, Lyke DF, Hertzberg RC, Haber L, Kohrman-Vincent M, Li R, et al. 2012. Cholinesterase inhibition and depression of the photic after discharge flash evoked potentials following acute or repeated exposures to a mixture of carbaryl and propoxur. Neurotoxicology 33(3):332–346.

Maier A, Kohrman-Vincent M, Hertzberg R, Allen B, Haber LT, Dourson M. 2012. Critical review of dose-response options for F344 rat mammary tumors for acrylamide – additional insights based on mode of action. Food Chem Toxicol 50(5):1763–1776.

Fowler, JC, Bhattacharya S, Urban JD, Vaidehi N, Mailman RB. 2012. Receptor conformations involved in dopamine D2L receptor functional selectivity induced by selected transmembrane 5 serine mutations. Mol Pharmacol 81(6):820-831; doi: 10.1124/mol.111.075457.

Lynch M, Brown L, Chun A, Reid J, Russel P. Risk communication for the Toxic Release Inventory. Poster presentation to Society for Risk Analysis, 2012.

Keller DA, Juberg DR, Catlin N, Farland WH, Hess FG, Wolf DC, Doerrer NG. 2012. Identification and characterization of adverse effects in 21st century toxicology. Toxicol Sci 126(2):291–297, doi: 10.1093/toxsci/kfr350.

Hinerman JM, Dignam JD, Mueser T. 2012. A model of the bacteriophage T4 59 helicase assembly protein:32 single stranded DNA binding protein binary complex and analysis of interaction with Pseudo-Y junction DNA. J Biol Chem 287(22):8608–8617.

Henderson RG, Durando J, Oller A, Merkel DJ, Marone PA,  Bates HK. 2012. Acute oral toxicity of nickel compounds. Regul Toxicol Pharmacol 62(3):425-432.

Thompson C, Perry C, Gaylor D, Tachovsky A, Burkhalter B, Haws L. Derivation of an oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. Presented at Society of Toxicology 50th Annual Meeting, Washington DC, March 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011

Sterner T, Ruark C, Covington T, Gearhart J. Monte Carlo and sensitivity analyses of a PBPK model for the oxime TMB-4. Poster presented at the Chemical and Biological Defense Science and Technology Conference, Las Vegas, NV, November 2011.